Digma Medical

medical devices

About

Digma aims to harness the power of the small intestine to empower patients and physicians with safe, simple and effective new therapies for type 2 diabetes that dramatically improve their quality of life and long-term health outcomes. We are developing a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body's natural ability to control blood glucose levels. The treatment targets the duodenal submucosa which is central to nutrient sensing and metabolic signaling . Our product is compatible with standard gastrointestinal endoscopes and the EGM procedure is being developed so that it can be performed in a standard GI endoscopy suite without requiring additional imaging equipment. Our goal is to provide patients with durable improvement in glycemic control with minimal side effects and without requiring additional daily medical therapy. The EGM procedure is currently being evaluated in clinical studies. To learn more about our clinical program, please contact us.

Technologies

Gmail Google Apps Microsoft Office 365 Google Cloud Hosting Mobile Friendly Varnish Wix Sisense Domo KNIME

Keywords

medical device type2 diabetes metabolic syndrome nash medical equipment manufacturing clinical studies contactless ablation healthcare equipment & supplies patient-centered solutions multi-zone ablation endoscopic laser ablation gastrointestinal diseases treatment laser balloon-catheter technology minimally invasive therapy clinical evaluation single-use catheter contactless laser ablation minimally invasive gi therapy outpatient procedure nir laser therapy b2b guided ablation healthcare technology medical devices therapeutic laser medical equipment and supplies manufacturing pre-cancerous condition therapy medical technology startup contactless tissue ablation high-risk disease management

Location

כיכר ישראל, Giv'at Shmuel, Center District, Israel, 54000

Related Companies

Companies in the same industry